Insider Trading
Current insider transactions (SEC Form 4) — buys and sells by officers, directors, and major shareholders.
| Ticker | Insider | Title | Date | Transaction | Price ($) | Shares | Value ($) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| ARTNA | Taylor Dian C | Director | 09/17/2026 | Verkauf | 35.29 | 2,000 | 70,580 | Form 4 |
| ARQT | Matsuda Masaru | See Remarks | 09/16/2026 | Verkauf | 25.00 | 3,674 | 91,853 | Form 4 |
| ARTNA | Taylor Dian C | Director | 09/16/2026 | Verkauf | 35.05 | 2,000 | 70,100 | Form 4 |
| ARQT | Welgus Howard G. | Director | 09/15/2026 | Verkauf | 24.18 | 4,730 | 114,371 | Form 4 |
| ARCB | Parks Jason T | VP - Controller(1) | 09/15/2026 | Verkauf | 135.09 | 855 | 115,502 | Form 4 |
| ARE | Fukuzaki-Carlson Kristina | EVP - Business Operations | 09/11/2026 | Verkauf | 50.51 | 16,810 | 849,073 | Form 4 |
| ARR | Staton Daniel C | Chairman of the Board | 09/10/2026 | Verkauf | 15.86 | 35,583 | 564,418 | Form 4 |
| ARBE | Arkind Noam | Chief Technology Officer | 09/08/2026 | Verkauf | 0.7796 | 278,800 | 217,352 | Form 4 |
| ARHS | Doody Alton F III | Director | 09/08/2026 | Verkauf | 8.47 | 3,500 | 29,645 | Form 4 |
| ARQT | Matsuda Masaru | See Remarks | 09/08/2026 | Verkauf | 25.03 | 9,989 | 249,986 | Form 4 |
| ARTV | Aslan Fred | Chief Executive Officer | 09/08/2026 | Verkauf | 10.92 | 23,429 | 255,746 | Form 4 |
| ARBE | Arkind Noam | Chief Technology Officer | 09/04/2026 | Verkauf | 0.6294 | 22,700 | 14,287 | Form 4 |
| ARBE | Arkind Noam | Chief Technology Officer | 09/03/2026 | Verkauf | 0.6321 | 35,800 | 22,629 | Form 4 |
| ARTV | Horan Christopher | Chief Tech Operations Officer | 09/03/2026 | Verkauf | 11.16 | 10,366 | 115,638 | Form 4 |
| ARTV | Bush Jennifer | COO, CLO, Compliance Officer | 09/03/2026 | Verkauf | 11.16 | 8,391 | 93,606 | Form 4 |
| ARTV | Banerjee Subhashis | Chief Medical Officer | 09/03/2026 | Verkauf | 11.16 | 1,100 | 12,271 | Form 4 |
| ARTV | Aslan Fred | Chief Executive Officer | 09/03/2026 | Verkauf | 11.16 | 61,888 | 690,392 | Form 4 |
| ARTNA | Taylor Dian C | Director | 09/03/2026 | Verkauf | 36.11 | 2,000 | 72,220 | Form 4 |
| ARW | Jean-Claude Carine Lamercie | SVP, CLCO and Secretary | 09/03/2026 | Verkauf | 209.85 | 1,000 | 209,850 | Form 4 |
| ARBE | Arkind Noam | Chief Technology Officer | 09/03/2026 | Verkauf | 0.6357 | 31,000 | 19,707 | Form 4 |
| ARTNA | Taylor Dian C | Director | 09/02/2026 | Verkauf | 36.00 | 1,124 | 40,464 | Form 4 |
| ARBE | Arkind Noam | Chief Technology Officer | 09/02/2026 | Verkauf | 0.6403 | 31,700 | 20,298 | Form 4 |
| ARLO | Rothstein Amy M | Director | 09/01/2026 | Verkauf | 12.55 | 6,149 | 77,150 | Form 4 |
| ARE | Gavinet Andres | Chief Accounting Officer | 08/31/2026 | Verkauf | 50.93 | 10,000 | 509,300 | Form 4 |
| ARTNA | Taylor Dian C | Director | 08/31/2026 | Verkauf | 35.50 | 2,000 | 71,000 | Form 4 |
| ARTNA | Taylor Dian C | Director | 08/28/2026 | Verkauf | 35.50 | 2,000 | 71,000 | Form 4 |
| ARTV | Banerjee Subhashis | Chief Medical Officer | 08/27/2026 | Verkauf | 12.01 | 8,222 | 98,736 | Form 4 |
| ARM | Child Jason | Chief Financial Officer | 08/27/2026 | Verkauf | 255.33 | 10,400 | 2,655,432 | Form 4 |
| ARQT | Curran Terrie | Director | 08/27/2026 | Verkauf | 25.03 | 27,052 | 677,095 | Form 4 |
| ARQT | Curran Terrie | Director | 08/27/2026 | Verkauf | 25.03 | 11,148 | 279,028 | Form 4 |
| ARI | Salvati Michael | Director | 08/25/2026 | Verkauf | 6.86 | 125 | 858 | Form 4 |
| ARI | Salvati Michael | Director | 08/25/2026 | Verkauf | 6.86 | 835 | 5,728 | Form 4 |
| ARTNA | Taylor Dian C | Director | 08/25/2026 | Verkauf | 35.68 | 2,000 | 71,360 | Form 4 |
| ARCO | Hernandez Artigas Carlos | Director | 08/25/2026 | Verkauf | 8.06 | 14,500 | 116,812 | Form 4 |
| ARCO | Hernandez Artigas Carlos | Director | 08/24/2026 | Verkauf | 8.16 | 2,569 | 20,964 | Form 4 |
| ARCO | Hernandez Artigas Carlos | Director | 08/24/2026 | Verkauf | 8.15 | 15,274 | 124,483 | Form 4 |
| ARX | Meriwether Karen Sue | Director | 08/21/2026 | Verkauf | 19.62 | 542 | 10,631 | Form 4 |
| ARDX | Hohenleitner Susan | Chief Financial Officer | 08/21/2026 | Verkauf | 3.86 | 1,558 | 6,009 | Form 4 |
| ARDX | Brady James Parker | Chief Human Resources Officer | 08/21/2026 | Verkauf | 3.86 | 13,160 | 50,757 | Form 4 |
| ARDX | Brady James Parker | Chief Human Resources Officer | 08/21/2026 | Verkauf | 3.86 | 1,976 | 7,621 | Form 4 |
| ARDX | Reilly Joseph James | See Remarks | 08/21/2026 | Verkauf | 3.86 | 1,110 | 4,281 | Form 4 |
| ARDX | Reilly Joseph James | See Remarks | 08/21/2026 | Verkauf | 3.86 | 2,872 | 11,077 | Form 4 |
| ARDX | Foster Eric Duane | Chief Commercial Officer | 08/21/2026 | Verkauf | 3.86 | 2,575 | 9,932 | Form 4 |
| ARDX | Foster Eric Duane | Chief Commercial Officer | 08/21/2026 | Verkauf | 3.86 | 3,389 | 13,071 | Form 4 |
| ARDX | Foster Eric Duane | Chief Commercial Officer | 08/21/2026 | Verkauf | 3.86 | 2,598 | 10,020 | Form 4 |
| ARDX | Kelliher Mike | Chief Business Officer | 08/21/2026 | Verkauf | 3.86 | 2,002 | 7,722 | Form 4 |
| ARDX | Kelliher Mike | Chief Business Officer | 08/21/2026 | Verkauf | 3.86 | 2,652 | 10,229 | Form 4 |
| ARDX | Kelliher Mike | Chief Business Officer | 08/21/2026 | Verkauf | 3.86 | 3,104 | 11,972 | Form 4 |
| ARDX | Williams Laura A | Chief Patient Officer | 08/21/2026 | Verkauf | 3.86 | 1,734 | 6,688 | Form 4 |
| ARDX | Williams Laura A | Chief Patient Officer | 08/21/2026 | Verkauf | 3.86 | 2,430 | 9,372 | Form 4 |
| ARDX | Williams Laura A | Chief Patient Officer | 08/21/2026 | Verkauf | 3.86 | 3,089 | 11,914 | Form 4 |
| ARDX | Williams Laura A | Chief Patient Officer | 08/21/2026 | Verkauf | 3.86 | 3,486 | 13,445 | Form 4 |
| ARDX | Raab Michael | President & CEO | 08/21/2026 | Verkauf | 3.86 | 19,178 | 73,968 | Form 4 |
| ARDX | Raab Michael | President & CEO | 08/21/2026 | Verkauf | 3.86 | 8,411 | 32,440 | Form 4 |
| ARDX | Raab Michael | President & CEO | 08/21/2026 | Verkauf | 3.86 | 15,976 | 61,618 | Form 4 |
| ARDX | Raab Michael | President & CEO | 08/21/2026 | Verkauf | 3.86 | 15,009 | 57,888 | Form 4 |
| ARDX | Bishop John E | See Remarks | 08/21/2026 | Verkauf | 3.86 | 2,469 | 9,523 | Form 4 |
| ARDX | Bishop John E | See Remarks | 08/21/2026 | Verkauf | 3.86 | 17,281 | 66,651 | Form 4 |
| ARQT | Curran Terrie | Director | 08/20/2026 | Verkauf | 26.04 | 1,072 | 27,912 | Form 4 |
| ARTNA | Taylor Dian C | Director | 08/20/2026 | Verkauf | 35.30 | 2,000 | 70,600 | Form 4 |
A compact market overview — not investment advice. Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q).